Income From Continuing Operations - Nanobiotix SA (PAR:NANO) - Alpha Spread

Nanobiotix SA
PAR:NANO

Watchlist Manager
Nanobiotix SA Logo
Nanobiotix SA
PAR:NANO
Watchlist
Price: 4.622 EUR -0.52%
Market Cap: 219.1m EUR
Have any thoughts about
Nanobiotix SA?
Write Note

Nanobiotix SA
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nanobiotix SA
Income from Continuing Operations Peer Comparison

Comparables:
VLA
IPH
GNFT
ALERS
OSE

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Nanobiotix SA
PAR:NANO
Income from Continuing Operations
-€39.7m
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-17%
Valneva SE
PAR:VLA
Income from Continuing Operations
-€7.7m
CAGR 3-Years
60%
CAGR 5-Years
N/A
CAGR 10-Years
12%
Innate Pharma SA
PAR:IPH
Income from Continuing Operations
-€34.1m
CAGR 3-Years
-62%
CAGR 5-Years
N/A
CAGR 10-Years
-13%
Genfit SA
NASDAQ:GNFT
Income from Continuing Operations
-€28.9m
CAGR 3-Years
34%
CAGR 5-Years
18%
CAGR 10-Years
-9%
Eurobio Scientific SA
PAR:ALERS
Income from Continuing Operations
€4.8m
CAGR 3-Years
-60%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
OSE Immunotherapeutics SA
PAR:OSE
Income from Continuing Operations
-€23m
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Nanobiotix SA's Income from Continuing Operations?
Income from Continuing Operations
-39.7m EUR

Based on the financial report for Dec 31, 2023, Nanobiotix SA's Income from Continuing Operations amounts to -39.7m EUR.

What is Nanobiotix SA's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-17%

Over the last year, the Income from Continuing Operations growth was 30%. The average annual Income from Continuing Operations growth rates for Nanobiotix SA have been -6% over the past three years , -6% over the past five years , and -17% over the past ten years .

Back to Top